![](/img/cover-not-exists.png)
* Cetuximab combined with multi-targeted sirna against HSP90, UBCH5, and SRC circumvented oncogene addiction, transactivation, and acquired resistance as a result of EGFR ubiquitination, and mutations/deletions in the kinase domain of EGFR in colorectal CA
Giannios, J.Volume:
60
Language:
english
Journal:
Gut
DOI:
10.1136/gut.2011.239301.234
Date:
April, 2011
File:
PDF, 70 KB
english, 2011